Bill Analyses and Ratings
Bill Information: S1346 – Two-Year Moratorium on Gene Therapy for Minors
Bill Summary
Senate Bill 1346, the ‘Maintaining Idaho Children’s Health Act,’ imposes a two-year moratorium prohibiting any person in Idaho from administering human gene therapy products for infectious disease indications to children under 18 or pregnant women. The bill defines ‘human gene therapy products’ broadly to include nucleic acids such as plasmids and mRNA, genetically modified microorganisms, engineered genome-editing nucleases, and ex vivo modified human cells — a definition that encompasses mRNA-based vaccines currently approved by the FDA.
The moratorium includes narrow exceptions: products used to treat cancer or genetic disorders are exempt, as are products administered under an active IRB-approved clinical trial or through FDA compassionate use/expanded access pathways for life-threatening conditions. The legislature may also exempt individual products after reviewing safety data, but only if the product is proven safe, informed consent procedures exist, and the manufacturer or administrator has assured compensation for adverse outcomes.
The bill takes effect immediately upon passage under an emergency declaration and remains in force for two years, after which the legislature must review available safety data before any extension or modification. No enforcement penalties are specified in the bill text for violations of the prohibition.
Overall Assessment
This bill’s most immediate real-world effect is blocking Idaho healthcare providers from administering mRNA-based vaccines and other gene therapy products for infectious diseases to anyone under 18 or pregnant, regardless of FDA approval status. Children and pregnant women who would otherwise receive these products — including currently available vaccines — lose access to them under Idaho law for at least two years. The bill directly conflicts with federal regulatory approvals, creating a state-federal tension that leaves providers legally exposed and patients without options that remain available in other states. The legislature retains sole authority to grant exemptions, concentrating medical product approval decisions in a political body rather than clinical or regulatory experts.
Rating Breakdown
ARTICLE I. RESPONSIBILITY IN GOVERNMENT (0)
The bill's legislative intent explicitly frames the moratorium as the state 'standing in the gap where regulatory agencies have failed,' invoking a state sovereignty rationale against federal regulatory authority. However, the bill simultaneously expands state government's role in healthcare decision-making by creating a new prohibition enforced through Idaho Code, which cuts against principles of limiting government growth. These competing impulses — asserting state authority over federal agencies while expanding state regulatory reach — produce no clear net alignment in either direction.
ARTICLE II. CITIZEN INVOLVEMENT IN GOVERNMENT (0)
The bill regulates the administration of medical products and has no provisions touching elections, voting procedures, civic participation, or political engagement. Its subject matter is entirely within the healthcare regulatory domain.
ARTICLE III. EDUCATION (0)
The bill addresses medical product administration and contains no provisions related to school curricula, parental rights in educational settings, school funding, or any other education policy matter.
ARTICLE IV. AGRICULTURE (0)
The bill concerns human gene therapy products used in medical contexts and has no connection to farming, ranching, agricultural markets, water rights for agriculture, or any other agricultural policy.
ARTICLE V. WATER (0)
The bill's subject matter — a moratorium on gene therapy products for minors and pregnant women — has no relationship to water appropriation, water rights, reservoir management, or any water policy matter.
ARTICLE VI. NATURAL RESOURCES AND ENVIRONMENT (0)
The bill regulates human medical products and has no bearing on natural resource stewardship, environmental policy, federal land management, or wilderness areas.
ARTICLE VII. ENERGY (0)
The bill addresses healthcare regulation and has no connection to energy production, energy independence, hydroelectric or nuclear power, or energy deregulation.
ARTICLE VIII. IDAHO NATIONAL LABORATORIES (0)
The bill concerns human gene therapy products for infectious disease indications and has no overlap with the Idaho National Laboratory's nuclear research, energy technology, or defense-related missions.
ARTICLE IX. PRIVATE PROPERTY RIGHTS (0)
The bill imposes a prohibition on administering certain medical products and does not touch property ownership, eminent domain, takings, or Fifth Amendment property protections.
ARTICLE X. STATE AND FEDERAL LANDS (0)
The bill addresses medical product administration and contains no provisions related to state or federal land ownership, land transfers, or land management policy.
ARTICLE XI. WILDLIFE MANAGEMENT (0)
The bill regulates human medical products and has no connection to fish and game management, hunting and fishing rights, predator control, or the Idaho Department of Fish and Game.
ARTICLE XII. ECONOMY (0)
While the moratorium restricts healthcare providers from administering certain products — potentially affecting medical practices, pharmacies, and related businesses — the bill does not address Idaho's broader commercial and industrial economy, small business regulation, labor markets, or transportation infrastructure. Any economic impact on healthcare providers is incidental to the bill's medical regulatory purpose rather than a direct economic policy intervention.
ARTICLE XIII. HEALTH AND WELFARE (-1)
The bill imposes a blanket government prohibition on administering FDA-approved gene therapy products for infectious diseases to children and pregnant women, which directly contradicts the principle of a private enterprise healthcare delivery system with minimal government regulation. Section 39-4810(2) removes the ability of parents, patients, and physicians to choose these products even when they are federally approved and clinically indicated, overriding rather than supporting parental medical decision-making authority. The broad definition in Section 39-4810(3) — capturing mRNA products and other currently approved vaccines — means the prohibition extends well beyond experimental products to established medical interventions, restricting healthcare access for Idaho's most vulnerable populations.
ARTICLE XIV. AMERICAN FAMILY (1)
The bill's stated purpose is to protect children, including those in the womb, from what the legislature characterizes as experimental gene therapy products, aligning with the principle that the state should act to safeguard children's health and safety. Section 39-4810(2) explicitly extends protection to unborn children, consistent with the position that human personhood and legal protection begin at conception. The exemption framework in Section 39-4810(6) — requiring proven safety, informed consent, and assured compensation before any product can be administered — reflects a parental-rights orientation that demands accountability from manufacturers before children are exposed to these products.
ARTICLE XV. OLDER AMERICANS (0)
The moratorium applies exclusively to children under 18 and pregnant women. Older Americans are entirely outside the bill's scope, and the bill contains no provisions affecting senior services, employment, or healthcare access for that population.
ARTICLE XVI. LAW AND ORDER WITH JUSTICE (0)
The bill creates a civil health prohibition but specifies no penalties, enforcement mechanisms, or criminal consequences for violations, limiting its engagement with law enforcement or justice system concerns. It does not address gun rights, criminal sentencing, drug policy, or any other criminal justice matter.
ARTICLE XVII. NATIONAL DEFENSE – SECURING THE BORDER (0)
The bill addresses state healthcare regulation and has no provisions related to military readiness, veterans' services, border security, or immigration policy.
ARTICLE XVIII. ELECTION OF JUDGES AND IDAHO SUPREME COURT JUSTICES (0)
The bill concerns medical product regulation and has no connection to judicial selection, judicial elections, constitutional interpretation methodology, or court structure.
ARTICLE XIX. RELIGIOUS LIBERTY (0)
The bill does not reference religious freedom, conscience protections, or the free exercise of religion. While the moratorium incidentally removes a source of conflict for those with religious objections to certain vaccines by banning the products outright, this is a byproduct of the prohibition rather than a religious liberty provision, and the bill creates no affirmative conscience protections or religious exemption framework.